Immunization News and Research

RSS

Can asymptomatic COVID-19 confer long-term immunity?

Researchers examined the antibody responses in symptomatic and asymptomatic individuals recovered from COVID-19 to see if there was a discernable difference in their humoral immune responses and long-term protection from reinfection with SARS-CoV-2.

1 Apr 2021

Could a flavonoid found in common fruit and vegetables combat COVID-19?

Researchers in India have gathered and presented a large body of evidence highlight quercetin – a flavonoid molecule found in many common fruits and vegetables – may be developed into drug therapies used to combat COVID-19.

1 Apr 2021

Researchers develop a recombinant SARS-CoV-2 receptor-binding domain trimer vaccine candidate

New research deals with the development of RBD trimer as a potent target for SARS-CoV-2 subunit vaccines. This study revealed the development of a trimeric RBD subunit vaccine candidate that could induce strong humoral and cellular immune responses in nonhuman primates (NHPs), namely, rhesus macaques.

1 Apr 2021

Antibody tests, even rapid finger pricks, are effective COVID-19 screening tools

New findings from a Michigan Medicine study reveal that antibody testing is predictive of prior COVID-19 infection, and rapid screening methods - even from finger pricks - are effective testing tools.

31 Mar 2021

2021 AGS Annual Scientific Meeting goes virtual for the first time

The worlds of work, education, and networking have changed drastically in the past year, and the American Geriatrics Society is evolving with them.

31 Mar 2021

mRNA COVID-19 vaccines are highly effective among front liners, CDC study shows

The study, published in CDC's Morbidity and Mortality Weekly Report (MMWR), highlights the efficacy of mRNA vaccines in protecting against SARS-CoV-2 infection.

30 Mar 2021

Single Sputnik V vaccine dose elicits robust immune response in previously infected individuals

A new preprint research paper posted to the medRxiv server describes successful immunization of the vaccinated population with a single dose of the Russian-made Sputnik V vaccine.

29 Mar 2021

‘Incredibly concerning’ lawsuit threatens no-charge preventive care for millions

With a challenge to the Affordable Care Act still pending at the Supreme Court, conservatives are continuing to launch legal attacks on the law, including a case in which a Texas federal judge seems open to ending the requirement that most Americans must receive preventive services like mammograms free of charge.

26 Mar 2021

Researchers conduct online survey on people’s intentions regarding COVID-19 vaccination

Ahead of the first U.S. emergency use authorization for a COVID-19 vaccine, only half of Americans said they were likely to get vaccinated as soon as possible, according to an in-depth study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

25 Mar 2021

Vaccination of health care workers resulted in notable reduction of COVID-19 cases

Vaccinating health care workers resulted in an immediate and notable reduction of positive COVID-19 cases among employees, reducing the number of required isolations and quarantines by more than 90 percent, according to data at UT Southwestern Medical Center published in the New England Journal of Medicine.

24 Mar 2021

‘Press 1 for English’: Vaccination sign-ups prove daunting for speakers of other languages

In late February, a week after Virginia launched a centralized website and call center for covid-19 vaccine preregistration, Zowee Aquino alerted the state to a glitch that could prove fatal for non-English speakers trying to secure a shot.

23 Mar 2021

Could nanoparticle vaccines offer broad protection against sarbecoviruses?

To understand the ability of SARS-CoV-2 vaccine-elicited antibodies to neutralize and protect against emerging variants (that are pathogenic) and other sarbecoviruses, a large team of researchers studied immunity by receptor-binding domain nanoparticle vaccines. They showed that a clinical-stage multivalent SARS-CoV-2 receptor-binding domain nanoparticle vaccine (SARS-CoV-2 RBD-NP) protected mice from the SARS-CoV-2-induced disease.

22 Mar 2021

Vaccine passports raise questions of equity, security, and privacy

Vaccine passports raise questions of equity, security, privacy, argues Crispin Maslog. China, where the COVID-19 pandemic began a long year ago, has now become the first country in the world to issue a vaccine passport to promote world economic recovery and facilitate cross-border travel.

22 Mar 2021

The case for donating US Covid vaccines overseas

A Senate committee grilled federal officials about the shortage of vaccines to protect Americans against a pandemic virus. Two months later, the U.S. public had lost interest in the virus, and millions of vaccines were sitting in warehouses — although poor countries still needed them.

19 Mar 2021

Mass vaccination needed to protect against future resurgences of COVID-19

The first long-term seroprevalence study of residents in Wuhan, China, has found that 6.9% of people in the city had antibodies against COVID-19 in April 2020, and 82% of these people had an asymptomatic infection.

19 Mar 2021

Can vaccine evading SARS-CoV-2 variants be restricted by prioritized vaccine rollout?

A new study discusses the question of how vaccine priority is affected by the possibility of vaccine escape.

18 Mar 2021

Arrayjet plays a key role in the development of anti-malarial vaccination

The quest to develop effective malarial vaccines is now a step closer with Scottish bio-printer manufacturer Arrayjet, selected to work with a Kenyan-based medical research group to assist ongoing R&D trials that could lead to a vaccination immunization program to tackle malaria in less than two years.

17 Mar 2021

Janssen’s vaccine added to list of safe, effective tools against COVID-19

The World Health Organization (WHO) today listed the COVID-19 vaccine Ad26.COV2.S, developed by Janssen (Johnson & Johnson), for emergency use in all countries and for COVAX roll-out. The decision comes on the back of the European Medicines Agency (EMA) authorization, which was announced yesterday.

16 Mar 2021

New strategy may change the course of evolving COVID-19 pandemic

Launched in April 2020 by the World Health Organization (WHO), European Commission, France and The Bill & Melinda Gates Foundation, the ACT Accelerator is a partnership of leading public health agencies with equity at its heart.

16 Mar 2021

New Phase 1 study evaluates prime/boost HIV-1 vaccine formulated with combinations of adjuvants

A new Phase 1 vaccine study began today that will evaluate experimental prime/boost HIV-1 vaccine regimens formulated with combinations of different adjuvants, including one from the Army Liposome Formulation (ALF) family of adjuvants developed by scientists with the U.S. Military HIV Research Program at the Walter Reed Army Institute of Research.

15 Mar 2021

Immunization News and Research

Can asymptomatic COVID-19 confer long-term immunity?

Could a flavonoid found in common fruit and vegetables combat COVID-19?

Researchers develop a recombinant SARS-CoV-2 receptor-binding domain trimer vaccine candidate

Antibody tests, even rapid finger pricks, are effective COVID-19 screening tools

2021 AGS Annual Scientific Meeting goes virtual for the first time

mRNA COVID-19 vaccines are highly effective among front liners, CDC study shows

Single Sputnik V vaccine dose elicits robust immune response in previously infected individuals

‘Incredibly concerning’ lawsuit threatens no-charge preventive care for millions

Researchers conduct online survey on people’s intentions regarding COVID-19 vaccination

Vaccination of health care workers resulted in notable reduction of COVID-19 cases

‘Press 1 for English’: Vaccination sign-ups prove daunting for speakers of other languages

Could nanoparticle vaccines offer broad protection against sarbecoviruses?

Vaccine passports raise questions of equity, security, and privacy

The case for donating US Covid vaccines overseas

Mass vaccination needed to protect against future resurgences of COVID-19

Can vaccine evading SARS-CoV-2 variants be restricted by prioritized vaccine rollout?

Arrayjet plays a key role in the development of anti-malarial vaccination

Janssen’s vaccine added to list of safe, effective tools against COVID-19

New strategy may change the course of evolving COVID-19 pandemic

New Phase 1 study evaluates prime/boost HIV-1 vaccine formulated with combinations of adjuvants

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News